Diabetes & Coronary Disease
Sort by:
Scripps Health
Medication Options for T2D: How Do You Determine Initial Treatment, and Which Agents Are Preferred in Patients With CVD, HF, and/or CKD?
FEATURING
Lauren Vincent
- 721 views
- January 18, 2021
- 5
Cardiometabolic Health Congress (CMHC)
What Is the Link Between Diabetes, CAD, and CVD?
FEATURING
Deepak Bhatt
- 94 views
- December 28, 2020
26th Annual San Diego Heart Failure Symposium
Q&A: Advances in Heart Failure Management
- 25 views
- December 17, 2020
26th Annual San Diego Heart Failure Symposium
SGLT2 Inhibitors and GLP-1 Receptor Agonists for Treating Type 2 Diabetes and Reducing Cardiovascular Risk
FEATURING
Pam Taub
- 893 views
- December 16, 2020
- 3
Piedmont Heart Institute Napa Valley Cardiology Conference
PCI vs CABG for Diabetes and Cardiovascular Risk
FEATURING
Joseph Woo
- 527 views
- November 15, 2019
- 6
Piedmont Heart Institute Napa Valley Cardiology Conference
Diabetes and Coronary Artery Disease: How do We Risk Stratify?
FEATURING
Robert Hendel
- 435 views
- November 15, 2019
- 5
Mount Sinai Advanced Innovations in Heart Failure Symposium 2019
Diabetes and Heart Failure: The New Frontier
FEATURING
Eugene Braunwald
- 47 views
- November 12, 2019
Cardiology Pulse 2019
Changing Landscape of CV Treatment in Type 2 Diabetes
FEATURING
Carolina Herrera
- 207 views
- October 30, 2019
- 2
Cardiology Pulse 2019
Top 5 Cardiovascular Prevention Trials
FEATURING
Robert Chilton
- 267 views
- October 30, 2019
- 3
Cardiometabolic Health Congress (CMHC)
Individualization of Treatment in T2DM Patients with CVD
FEATURING
Harold Bays
- 528 views
- October 22, 2019
- 5